Wasn't brave enough to take the plunge at around $25 - would have been a nice earner even on my very modest probable purchase -how higher can it go, which more than 1 of us has been saying since about $10 or so
Printable View
Wasn't brave enough to take the plunge at around $25 - would have been a nice earner even on my very modest probable purchase -how higher can it go, which more than 1 of us has been saying since about $10 or so
I’m sure FPH will benefit from the current situation but if you think it’s to the same level as a biotech involved in this space you are dreaming
Hospitals aren’t going to be stockpiling their products specifically
Great company and great products and many more to come, but the PE ratio is way too high for the growth it is hoping to achieve. I would rather go 100% in ATM than in FPH. Still this company is a great company, but I would not be buying unless it was lower than $18 per share. Just my opinion and I have been wrong so far as everyone is buying their boots full
Note that FPH units are also used in non-ICU settings as well (i.e. to avoid deteriorating further, or in recovery), and for both nasal high flow as well as intubated patients. And yes, there are other competitors products. So it is hard to estimate the % of patients on FPH units.
nm ...................
When the dust settles, and the hospitals revert to business as usual, there are going to be so many ventilators sloshing around that I wonder if FPH will be able to sell any for the next 10 years or so.
I assume that the ventilators being produced by unconventional suppliers (Ford, GM, Dyson, etc.) will be basic models - so FPH's models may well be better and still have a niche market.
Any thoughts?
Agree. I think many countries have been caught on the hop and will decide (& rightly so) that the production of medical equipment (ventilators, masks etc,) is in the national interest and will start making their own.
I think this could be true. However, in terms of not able to sell in the future because there is an excess, that is less of a concern. FPH makes humidifers not ventilators and the main revenues come from consumables, not the device itself. So I think while the demand will drop back, it won't be as bad as those who make ventilators.
The bigger effect may come from less people having flu or respiratory illness due to the awareness and prevention.
The thing is, will Covid19 ever go away? Or just the severity / impact is reduced? Even with flu vaccines, it is still affecting so many people. Covid 19 is more contagious with longer incubation time. Can we really eliminate it or just keep it under control?
Grant Robertson was just asked if FPH had been approached with regards to making Ventilators. He neither confirmed nor denied